These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16269198)

  • 21. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
    J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.
    Greco F; Vicent MJ; Penning NA; Nicholson RI; Duncan R
    J Drug Target; 2005; 13(8-9):459-70. PubMed ID: 16332571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
    Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
    Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
    Tang A; Kopeiková P; Kopeckevá J
    Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.
    Pan H; Sima M; Yang J; Kopeček J
    Macromol Biosci; 2013 Feb; 13(2):155-60. PubMed ID: 23339052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of EMF-BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma.
    Říhová B; Etrych T; Šírová M; Tomala J; Ulbrich K; Kovář M
    J Drug Target; 2011 Dec; 19(10):890-9. PubMed ID: 21981636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
    Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
    Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H; Etrych T; Ríhová B; Kostka L; Starovoytová L; Kovář M; Ulbrich K
    Macromol Biosci; 2013 Dec; 13(12):1648-60. PubMed ID: 24031022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.
    Lammers T; Kühnlein R; Kissel M; Subr V; Etrych T; Pola R; Pechar M; Ulbrich K; Storm G; Huber P; Peschke P
    J Control Release; 2005 Dec; 110(1):103-18. PubMed ID: 16274831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel α
    Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
    J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
    Zhou Z; Xu X; Li L; Huang Y
    J Drug Target; 2015; 23(9):821-31. PubMed ID: 25830626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics.
    Ríhová B; Kovár L; Kovár M; Hovorka O
    Trends Biotechnol; 2009 Jan; 27(1):11-7. PubMed ID: 19022512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia.
    Kovár M; Mrkvan T; Strohalm J; Etrych T; Ulbrich K; Stastný M; Ríhová B
    J Control Release; 2003 Oct; 92(3):315-30. PubMed ID: 14568412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.
    Etrych T; Tsukigawa K; Nakamura H; Chytil P; Fang J; Ulbrich K; Otagiri M; Maeda H
    Eur J Pharm Sci; 2017 Aug; 106():10-19. PubMed ID: 28528285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo anti-tumor activity of a new doxorubicin conjugate via α-linolenic acid.
    Huan M; Cui H; Teng Z; Zhang B; Wang J; Liu X; Xia H; Zhou S; Mei Q
    Biosci Biotechnol Biochem; 2012; 76(8):1577-9. PubMed ID: 22878199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.
    Minko T; Kopecková P; Kopecek J
    Int J Cancer; 2000 Apr; 86(1):108-17. PubMed ID: 10728603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
    Tu J; Sun HX; Ye YP
    J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.